Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
Appili Therapeutics Inc banner

Appili Therapeutics Inc
TSX:APLI

Watchlist Manager
Appili Therapeutics Inc Logo
Appili Therapeutics Inc
TSX:APLI
Watchlist
Price: 0.005 CAD -50% Market Closed
Market Cap: CA$661.9k
Write Note Create Alert

Intrinsic Value

APLI doesn't have a meaningful market cap.

Is APLI undervalued or overvalued?

See the intrinsic value estimate for Appili Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

APLI Intrinsic Value
LOCKED
Unlock
Today vs. history

APLI looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with APLI’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor APLI
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Current Price CA$0.01
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to APLI

Fundamental Analysis

What Appili Therapeutics Does

Pharmaceuticals Health Care

Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. The company is headquartered in Halifax, Nova Scotia. The company went IPO on 2019-06-25. The firm is advancing a diverse range of anti-infectives, including an FDA-approved ready-made suspension of metronidazole for the treatment of antimicrobial-resistant infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical antiparasitic for the treatment of a disfiguring disease.

Headquarters
Canada CA
Employees
7
IPO date
Jun 25, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Appili Therapeutics Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Continue APLI Research

Summary
APLI intrinsic value, competitors valuation, and company profile.
DCF Valuation
APLI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
APLI stock valuation using valuation multiples.
Wall St Estimates
APLI price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
APLI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other Appili Therapeutics Inc listings:
OTC • USD
APLIF
Discover More
What is the Intrinsic Value of one APLI stock?

The intrinsic value for Appili Therapeutics Inc (APLI) under the Base Case is hidden CAD.

Is APLI stock undervalued or overvalued?

Compared with the current market price of 0.005 CAD, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 362,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.